Subscribe to Breaking News emails

You have successfully subscribed to the Breaking News email.

Subscribe today to be the first to to know about breaking news and special reports.

Senate Panel Opens Probe of EpiPen Price Hike

by Jon Schuppe /
A boy holds an Epipen that he uses to counteract allergic reactions.LUCAS TRIEB / AFP - Getty Images

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.

A Senate panel announced Wednesday that it would begin examining drugmaker Mylan Pharmaceuticals' massive markup on EpiPens, a device used by millions of Americans to prevent fatal allergic reactions.

The Permanent Subcommittee on Investigations has opened a "preliminary inquiry" on the matter, according to a joint statement from the panel's chairman, Rob Portman of Ohio, and ranking member Claire McCaskill of Missouri.

"Our review of this matter will be robust, thorough, and bipartisan," they said. "Parents and school districts in Ohio, Missouri and across the country need affordable access to this life-saving drug, and we share their concern over Mylan’s sustained price increases.”

Related: EpiPen Price Hike Has Parents of Kids With Allergies Scrambling Ahead of School Year

The price of an EpiPen in the United States has risen from around $100 to more than $500 since 2008, doctors and patients say.

Mylan has no competition, maintaining a virtual monopoly over a product that has become a part of daily life for people suffering from potentially deadly allergies, such as to nuts or bee stings.

The device, about the size of a marker, is loaded with epinephrine, and in the event of an allergic reaction, is jammed into the victim's thigh to stop them from going into anaphylactic shock.

Other members of the Senate have demanded Mylan reconsider the price hike, or called for hearings.

Related: Industry Insiders Estimate EpiPen Costs No More Than $30

Mylan CEO Heather Bresch told CNBC last month that the EpiPen's label price grew bigger as as it passed through middlemen on its way from manufacture to market. She pledged to find ways to "ensuring that everybody who needs an EpiPen has an EpiPen."

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.

The company says it is giving insured patients a $300 coupon and is developing a cheaper generic version. It also says it has given away hundreds of thousands of free devices.

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.
MORE FROM news

Have feedback?

How likely are you to recommend nbcnews.com to a friend or colleague?

0 = Very unlikely
10 = Very likely
Please select answer

Is your feedback about:

Please select answer

Leave your email if you’d like us to respond. (Optional)

Please enter a valid email address

Thank you!

Your feedback has been sent out. Please enjoy more of our content.

We appreciate your help making nbcnews.com a better place.